The interval colorectal cancer rate is a robust indicator of the quality and effectiveness of a screening programme, enabling the identification of unmet requirements and development of specific strategies to resolve them. A recent study demonstrated the use of interval cancer as an indicator to target quality improvement of colonoscopy in a screening programme.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7/TGFβ-mediated epithelial to mesenchymal transition
Molecular Cancer Open Access 17 January 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Chiu, S. Y. et al. Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program. Gut http://dx.doi.org/gutjnl-2015-310256 (2015).
Stoop, E. M. et al. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol. 13, 55–64 (2012).
van Rossum, L. G. et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 135, 82–90 (2008).
de Wijkerslooth, T. R. et al. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia. Am. J. Gastroenterol. 107, 1570–1578 (2012).
Sanduleanu, S. et al. Definition and taxonomy of interval colorectal cancers: a proposal for standardising nomenclature. Gut 64, 1257–1267 (2015).
le Clercq, C. M. et al. Metachronous colorectal cancers result from missed lesions and non-compliance with surveillance. Gastrointest. Endosc. 82, 325–333 (2015).
Kaminski, M. F. et al. Quality indicators for colonoscopy and the risk of interval cancer. N. Engl. J. Med. 362, 1795–1803 (2010).
Corley, D. A. et al. Adenoma detection rate and risk of colorectal cancer and death. N. Engl. J. Med. 370, 1298–1306 (2014).
Hazewinkel, Y. & Dekker, E. Colonoscopy: basic principles and novel techniques. Nat. Rev. Gastroenterol. Hepatol. 8, 554–564 (2011).
Lee, T. J. et al. Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme. Gut 61, 1050–1057 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
E.D. declares a research grant and endoscopic equipment on loan from Olympus Europe as well as equipment on loan from Fuji Japan. S.S. has a research grant and endoscopic equipment on loan from Pentax Europe.
Rights and permissions
About this article
Cite this article
Dekker, E., Sanduleanu, S. Strategies to minimize interval CRC in screening programmes. Nat Rev Gastroenterol Hepatol 13, 10–12 (2016). https://doi.org/10.1038/nrgastro.2015.216
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2015.216
This article is cited by
-
miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7/TGFβ-mediated epithelial to mesenchymal transition
Molecular Cancer (2017)
-
Proteomics analysis of up-regulated NPM1 protein in colorectal cancer
Chemical Research in Chinese Universities (2016)